Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars
Sign Up to like & getrecommendations! Published in 2019 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4809
Abstract: As more biosimilars become available in the United States, postapproval noninterventional studies describing biosimilar switching and comparing effectiveness and/or safety between switchers and nonswitchers will play a key role in generating real‐world evidence to inform… read more here.
Keywords: studies switching; reference biologic; noninterventional studies; switching reference ... See more keywords
Switching from reference adalimumab to biosimilar. Assessment of clinical outcomes in psoriasis
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Dermatology"
DOI: 10.1111/ijd.16399
Abstract: hypertrichosis in this child. The treatment was stopped, and the patient was switched back to tacrolimus. No treatment was performed on our pediatric patients because safe treatment was a priority over cosmetic needs. Acquired local… read more here.
Keywords: biosimilar assessment; reference adalimumab; hypertrichosis; alopecia areata ... See more keywords